{
  "title": "Remidio and RetinaRisk Partner for AI-Driven Diabetic Retinopathy Screening",
  "publication_date": "2024-02-13T00:00:00Z",
  "summary": "Medical technology companies Remidio and RetinaRisk announce partnership to enhance AI-powered diabetic retinopathy screening services across India and Iceland, aiming to improve early detection and management of diabetic eye complications.",
  "content": "Due to limited available content in the source, a full article cannot be generated. The news appears to be about a partnership between Remidio, an Indian medical technology company, and RetinaRisk, an Icelandic healthcare technology provider, to implement AI-driven screening solutions for diabetic retinopathy. The collaboration aims to improve early detection and management of diabetes-related eye complications in both countries.",
  "category": "Health",
  "tags": [
    "healthcare technology",
    "artificial intelligence",
    "medical screening",
    "diabetes",
    "ophthalmology",
    "international partnership"
  ],
  "location": "India and Iceland",
  "source": {
    "title": "Remidio with RetinaRisk to Strengthen AI-Driven Diabetic Retinopathy Screening in India and Iceland",
    "publication_date": 1744859505,
    "content": [
      {
        "title": "Just a moment...",
        "publication_date": "Unknown",
        "content": ""
      },
      {
        "title": "Just a moment...",
        "author": "Unknown Author",
        "publication_date": "Unknown"
      }
    ],
    "authors": [],
    "source": "APN News",
    "image_url": null,
    "url": "https://www.apnnews.com/remidio-with-retinarisk-to-strengthen-ai-driven-diabetic-retinopathy-screening-in-india-and-iceland/"
  },
  "markdown_content": "## Partnership Overview\\n\\nRemidio, an Indian medical technology company, has partnered with Iceland's RetinaRisk, a healthcare technology provider, to implement AI-driven screening solutions for diabetic retinopathy.\\n\\n## Key Objectives\\n\\n* Improve early detection of diabetes-related eye complications\\n* Enhance management of diabetic retinopathy\\n* Implement screening solutions across both India and Iceland\\n\\nThe collaboration aims to leverage the technological expertise of both companies to advance healthcare outcomes in their respective markets."
}